ChiCTR2200061863
正在进行
/
/
/
2022-07-05
/
/
Post-traumatic stress disorder symptoms
Effects of mindfulness-based cognitive therapy for adults with post-traumatic stress disorder symptoms in primary care: a randomised controlled trial
Effects of mindfulness-based cognitive therapy for adults with post-traumatic stress disorder symptoms in primary care: a randomised controlled trial
1. To evaluate the effectiveness of mindfulness-based cognitive therapy in reducing PTSD symptoms among adults when compared to a psychoeducation group. 2. To evaluate the effectiveness of mindfulness-based cognitive therapy in reducing depressive and anxiety symptoms among adults with PTSD symptoms when compared to a psychoeducation group. 3. To explore whether improved attentional control, reduced avoidance and reduced ruminative thoughts are potential mediators of the intervention and outcomes for PTSD symptoms among adults in Hong Kong.
病例对照研究
Ⅰ期
The method of sampling will be a stratified randomization based on gender and psychiatric medication use to achieve demographic balance between the two arms. The randomisation sequence will be generated by an experienced independent statistician using computer-generated random results.
Not stated
General Research Fund
/
80
/
2021-03-11
2025-06-13
/
1. Aged 18 years or above; 2. Score 33 or above in the Post-traumatic Stress Disorder Checklist (PCL-5) of the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, which is the cut-off score used in previous research to indicate significant PTSD symptoms 44; 3. Presence of PTSD symptoms for more than 1 month; 4. If taking psychiatric medications, must have been on a stable dosage for at least three months.；
请登录查看1. Inability to communicate and understand Chinese; 2. Possession of physical illness with moderate to severe disability or mental illness (e.g., suicidal ideation, schizophrenia, psychosis, and substance abuse); 3. Previous participation in a structured mindfulness-based training programme.；
请登录查看香港中文大學
/
复旦大学附属儿科医院2026-06-12
医药观澜2026-06-12
干细胞与外泌体2026-06-12
生物技术小编2026-06-12
细胞与基因治疗领域2026-06-12
基石药业官微2026-06-12
信达生物2026-06-12
生物天使2026-06-12
医药笔记2026-06-12
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
